Effects of Physiological and Pathological Urea Concentrations on Human Microvascular Endothelial Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
30 Dec 2022
Historique:
received: 15 09 2022
revised: 03 12 2022
accepted: 09 12 2022
entrez: 8 1 2023
pubmed: 9 1 2023
medline: 11 1 2023
Statut: epublish

Résumé

Urea is the uremic toxin accumulating with the highest concentration in the plasma of chronic kidney disease (CKD) patients, not being completely cleared by dialysis. Urea accumulation is reported to exert direct and indirect side effects on the gastrointestinal tract, kidneys, adipocytes, and cardiovascular system (CVS), although its pathogenicity is still questioned since studies evaluating its side effects lack homogeneity. Here, we investigated the effects of physiological and pathological urea concentrations on a human endothelial cell line from the microcirculation (Human Microvascular Endothelial Cells-1, HMEC-1). Urea (5 g/L) caused a reduction in the proliferation rate after 72 h of exposure and appeared to be a potential endothelial-to-mesenchymal transition (EndMT) stimulus. Moreover, urea induced actin filament rearrangement, a significant increase in matrix metalloproteinases 2 (MMP-2) expression in the medium, and a significant up- or down-regulation of other EndMT biomarkers (keratin, fibrillin-2, and collagen IV), as highlighted by differential proteomic analysis. Among proteins whose expression was found to be significantly dysregulated following exposure of HMEC-1 to urea, dimethylarginine dimethylaminohydrolase (DDAH) and vasorin turned out to be down-regulated. Both proteins have been directly linked to cardiovascular diseases (CVD) by in vitro and in vivo studies. Future experiments will be needed to deepen their role and investigate the signaling pathways in which they are involved to clarify the possible link between CKD and CVD.

Identifiants

pubmed: 36614132
pii: ijms24010691
doi: 10.3390/ijms24010691
pmc: PMC9821335
pii:
doi:

Substances chimiques

Urea 8W8T17847W
Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : University of Milan
ID : B Piano di Sostegno alla Ricerca 2018-Linea 2

Références

J Extracell Vesicles. 2012 Apr 16;1:
pubmed: 24009886
Clin J Am Soc Nephrol. 2011 Jul;6(7):1714-21
pubmed: 21642364
Oncogene. 2011 Apr 21;30(16):1912-22
pubmed: 21170088
Clin Sci (Lond). 2017 Jan 1;131(1):3-12
pubmed: 27872172
Bio Protoc. 2016 Nov 5;6(21):
pubmed: 28573164
Oncotarget. 2018 Jun 5;9(43):27117-27132
pubmed: 29930755
Nat Clin Pract Nephrol. 2008 Dec;4(12):672-81
pubmed: 18825155
Front Med (Lausanne). 2018 Dec 04;5:335
pubmed: 30564578
Proteomics. 2011 Jun;11(12):2459-75
pubmed: 21595033
Biomol Ther (Seoul). 2015 Jul;23(4):301-12
pubmed: 26157545
Iran J Kidney Dis. 2015 May;9(3):239-48
pubmed: 25957429
Biochim Biophys Acta. 2016 Apr;1863(4):572-80
pubmed: 26775586
Circulation. 2008 Oct 21;118(17):1748-57
pubmed: 18838561
Clin Sci (Lond). 2010 Apr 28;119(3):111-21
pubmed: 20443781
Life Sci. 2017 Sep 1;184:95-102
pubmed: 28716564
Am J Physiol Heart Circ Physiol. 2012 Feb 1;302(3):H499-505
pubmed: 22081698
Free Radic Biol Med. 2009 Sep 15;47(6):675-83
pubmed: 19527783
Clin Chem. 2005 Apr;51(4):719-28
pubmed: 15684275
J Nippon Med Sch. 2017;84(4):148-159
pubmed: 28978894
Physiol Rev. 2019 Apr 1;99(2):1281-1324
pubmed: 30864875
Methods Mol Biol. 2012;878:121-35
pubmed: 22674130
Int J Mol Sci. 2021 Jul 26;22(15):
pubmed: 34360735
Kidney Int. 2003 May;63(5):1934-43
pubmed: 12675874
Int J Artif Organs. 2001 Oct;24(10):695-725
pubmed: 11817319
Am J Nephrol. 2008;28(2):224-37
pubmed: 17960061
J Ren Nutr. 2015 Mar;25(2):155-9
pubmed: 25511523
Prog Mol Biol Transl Sci. 2017;147:1-73
pubmed: 28413025
Biochem Biophys Res Commun. 2012 Jan 6;417(1):479-83
pubmed: 22172950
Semin Dial. 2005 May-Jun;18(3):203-11
pubmed: 15934967
Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3227-45
pubmed: 17933965
Mol Med Rep. 2018 Feb;17(2):2827-2836
pubmed: 29257293
Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L1-8
pubmed: 17384082
Toxins (Basel). 2018 Oct 11;10(10):
pubmed: 30314315
Clin Chem. 2006 Apr;52(4):601-23
pubmed: 16484333
Cell. 2016 Mar 10;164(6):1226-1232
pubmed: 26967288
Lancet. 2017 Mar 25;389(10075):1238-1252
pubmed: 27887750
Nat Med. 2007 Feb;13(2):198-203
pubmed: 17273169
Semin Nephrol. 2013 Mar;33(2):93-105
pubmed: 23465497
Diab Vasc Dis Res. 2010 Apr;7(2):105-18
pubmed: 20382774
Circ J. 2017 Jul 25;81(8):1075-1084
pubmed: 28680012
Am J Kidney Dis. 2008 Apr;51(4):603-12
pubmed: 18371536
Int J Biol Sci. 2018 Mar 11;14(4):461-470
pubmed: 29725267
Semin Nephrol. 2004 Sep;24(5):469-73
pubmed: 15490413
Cell Stem Cell. 2018 Jan 4;22(1):104-118.e6
pubmed: 29198941
J Clin Med. 2016 Jan 27;5(2):
pubmed: 26828526
Dev Dyn. 1999 Jan;214(1):81-91
pubmed: 9915578
Kidney Int Suppl. 2009 Dec;(114):S12-9
pubmed: 19946322
Biochem Biophys Res Commun. 2015 Jul 31;463(3):377-83
pubmed: 26028560
Am J Pathol. 2000 Oct;157(4):1259-68
pubmed: 11021830
Basic Res Cardiol. 2008 Mar;103(2):95-104
pubmed: 18324365
Mol Cell. 2011 Jun 10;42(5):597-609
pubmed: 21658601
Clin J Am Soc Nephrol. 2008 Mar;3(2):505-21
pubmed: 18184879
Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):27-33
pubmed: 21160065
Oncotarget. 2018 Jan 19;9(13):11020-11045
pubmed: 29541394
Proteomics Clin Appl. 2010 Jul;4(6-7):644-53
pubmed: 21137083
Atherosclerosis. 2015 Apr;239(2):393-400
pubmed: 25682038
Oncotarget. 2015 Apr 30;6(12):10045-59
pubmed: 25826090
Biomol Concepts. 2012 Apr;3(2):161-73
pubmed: 25436530
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1476-84
pubmed: 21677290
Adv Pharmacol. 2018;81:241-330
pubmed: 29310800
Lancet. 2013 Jul 20;382(9888):260-72
pubmed: 23727169
Cell Tissue Res. 2010 Jan;339(1):71-82
pubmed: 19513754
Cell Signal. 2019 Dec;64:109414
pubmed: 31505229
Curr Opin Cardiol. 2003 Sep;18(5):372-7
pubmed: 12960470
Anal Biochem. 2014 Dec 15;467:1-3
pubmed: 25193447
Cell Mol Life Sci. 2007 Nov;64(22):2859-62
pubmed: 17876516
Dev Dyn. 2018 Mar;247(3):492-508
pubmed: 28891150
Artif Organs. 2004 Mar;28(3):248-53
pubmed: 15046622
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10732-7
pubmed: 15247411
J Clin Invest. 2010 Jan;120(1):203-13
pubmed: 19955654

Auteurs

Graziano Colombo (G)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, 20133 Milan, Italy.

Alessandra Altomare (A)

Department of Pharmaceutical Sciences, Università degli Studi di Milano, 20133 Milan, Italy.

Emanuela Astori (E)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, 20133 Milan, Italy.

Lucia Landoni (L)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, 20133 Milan, Italy.

Maria Lisa Garavaglia (ML)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, 20133 Milan, Italy.

Ranieri Rossi (R)

Department of Biotechnology, Chemistry and Pharmacy (Department of Excellence 2018-2022), University of Siena, 53100 Siena, Italy.

Daniela Giustarini (D)

Department of Biotechnology, Chemistry and Pharmacy (Department of Excellence 2018-2022), University of Siena, 53100 Siena, Italy.

Maria Chiara Lionetti (MC)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, 20133 Milan, Italy.

Nicoletta Gagliano (N)

Department of Biomedical Sciences for Health, Università degli Studi di Milano, 20133 Milan, Italy.

Aldo Milzani (A)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, 20133 Milan, Italy.

Isabella Dalle-Donne (I)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, 20133 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH